Abstract:Background/Aims: Cellular hypertrophy is an early important pathological feature of renal diseases such as diabetic nephropathy and remnant kidney. Recent studies have demonstrated that angiotensin II (Ang II) might be a major contributor in regulating cell hypertrophy. However, the exact mechanism is still unclear. The aim of our present work was to investigate the possible role of a newly clarified fibrogenic factor, connective tissue growth factor (CTGF), in mediating the effect of Ang II-induced tubular cell hypertrophy. Methods: The cell line HK2 was grown in Dulbecco’s modified Eagle’s medium containing 10% heat-inactivated fetal calf serum. After the cells were rested in serum-free medium for 24 h, the dose and time response of CTGF mRNA expression to Ang II stimulation was observed by RT-PCR, and protein synthesis was observed by Western blotting. The effect of anti-CTGF on Ang II (10–7M)-induced [3H]-leucine incorporation, total protein content (Coomassie brilliant blue G250 method) and change in cellular size [determined by a scanning electronic microscope (SEM)] was also observed. The influence of anti-CTGF antibody on the cell cycle was analyzed by using a fluorescence-activated cell sorter flow cytometer. Results: The results showed that Ang II induced expression of CTGF mRNA in a time- and dose-dependent manner (p < 0.05 and 0.01, respectively). Stimulation of cells with Ang II (10–7M) for 48 h resulted in a 92% increase in [3H]-leucine incorporation (5,584 cpm/105 cells at 0 h vs. 10,741 cpm/105 cells at 48 h; p = 0.01), which was significantly abolished by treatment with anti-CTGF antibody. Ang II (10–7M) significantly increased the total protein content in HK2 cells (control: 0.169 ± 0.011 mg/105 cells vs. Ang II: 0.202 ± 0.010 mg/105 cells; p = 0.03), which was markedly inhibited by cotreatment with anti-CTGF antibody. The average cellular diameter determined by SEM showed that the increase in cell size induced by Ang II could be significantly inhibited by anti-CTGF antibody (control: 11.92 ± 1.62 µm, Ang II group: 20.63 ± 3.83 µm, Ang II + anti-CTGF group: 16.43 ± 3.23 µm; p < 0.01, respectively). Furthermore, the flow cytometer study showed that Ang II arrested the cell cycle at G0–G1 phase, which was significantly reversed by treatment with anti-CTGF antibody (G0–G1 percentage: in Ang II group: 76 ± 1.8%, in Ang II + anti-CTGF group: 71 ± 1.78%; p = 0.04). Conclusion: Our data are the first to clearly demonstrate that CTGF might be an important mediator of Ang II-induced renal hypertrophy, which suggests that inhibiting the production of CTGF might be the new strategy in early prevention of renal fibrosis.

Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.

Ang II Enhances Atrial Fibroblast Autophagy and Promotes Atrial Remodeling Through the AT1-ERK-mTOR Signaling Pathway

Angiotensin II Induces Connective Tissue Growth Factor Expression in Human Hepatic Stellate Cells by a Transforming Growth Factor Β -Independent Mechanism

TRIF Promotes Angiotensin II-induced Cross-Talk Between Fibroblasts and Macrophages in Atrial Fibrosis.

Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor–Specific Arkadia-Mediated Downregulation of Smad7

Role of Connective Tissue Growth Factor in Mediating Hypertrophy of Human Proximal Tubular Cells Induced by Angiotensin II.

Role of the MAPKs/TGF-β1/TRAF6 Signaling Pathway in Atrial Fibrosis of Patients with Chronic Atrial Fibrillation and Rheumatic Mitral Valve Disease.

Angiotensin II-stimulated Collagen Synthesis in Aortic Adventitial Fibroblasts is Mediated by Connective Tissue Growth Factor.

Advanced Glycation End-Products Induce Tubular CTGF Via TGF-beta-independent Smad3 Signaling.

Connective Tissue Growth Factor-Mediated Angiotensin II-Induced Hypertrophy of Proximal Tubular Cells

AT1 Receptor‐specific Down‐regulation of Smad7 Plays a Key Role in Atrial Fibrillation‐Induced Myocardial Fibrosis

Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation Via TGF-β1/Smad2/α-SMA Pathway

Influence of Connective Tissue Growth Factor Antisense Oligonucleotide on Angiotensin II-induced Epithelial Mesenchymal Transition in HK2 Cells

Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts

Activin A Stimulates the Proliferation and Differentiation of Cardiac Fibroblasts Via the ERK1/2 and P38-Mapk Pathways

[Role of Connective Tissue Growth Factor in Angiotensin II Induced Human Proximal Tubular Cell Hypertrophy].

Ets-1 Upregulation Mediates Angiotensin II-related Cardiac Fibrosis.

Tadalafil Attenuates Angiotensin II-Induced Extracellular Matrix Remodeling in Cardiac Fibroblasts Through TGF-β1/Smad3 Signaling Pathway

Novel Role of the Clustered Mir‐23b‐3p and Mir‐27b‐3p in Enhanced Expression of Fibrosis‐associated Genes by Targeting TGFBR3 in Atrial Fibroblasts